- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Clearside Biomedical Inc (CLSD)
Clearside Biomedical Inc stock price live, this page displays NASDAQ CLSD stock exchange data. View the CLSD premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Clearside Biomedical Inc real time stock price chart below.
What Is the Clearside Biomedical Inc Stock Price Today?
The Clearside Biomedical Inc stock price today is 1.015.
What Is the Stock Symbol for Clearside Biomedical Inc?
The stock symbol for Clearside Biomedical Inc is "CLSD."
What Stock Exchange Does Clearside Biomedical Inc Trade On?
Clearside Biomedical Inc is listed and trades on the NASDAQ stock exchange.
Is Clearside Biomedical Inc a Good Stock to Buy?
Determining whether Clearside Biomedical Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CLSD quote. (ISIN: US1850631045)
What Is the Clearside Biomedical Inc Stock Price Today?
The Clearside Biomedical Inc stock price today is 1.015.
What Is the Stock Symbol for Clearside Biomedical Inc?
The stock symbol for Clearside Biomedical Inc is "CLSD."
What Stock Exchange Does Clearside Biomedical Inc Trade On?
Clearside Biomedical Inc is listed and trades on the NASDAQ stock exchange.
Is Clearside Biomedical Inc a Good Stock to Buy?
Determining whether Clearside Biomedical Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CLSD quote. (ISIN: US1850631045)
1.015
-0.015(-1.46%)
Closed
Pre Market
1.000-0.015(-1.48%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.010
1.040
52 wk Range
0.774
1.760
CLSD Scorecard
Full Analysis
4 analysts have revised their earnings upwards for the upcoming period
Earnings results expected tomorrow
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.0101.040
52 wk Range
0.7741.760
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CLSD Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
6.000
Upside
+491.13%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Clearside Biomedical Inc Company Profile
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. It offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase IIb clinical trial to treat wet AMD. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.
Clearside Biomedical Inc SWOT Analysis
Innovative Eye Therapy | Clearside Biomedical's suprachoroidal delivery platform for wet AMD treatment shows promise, with potential advantages over traditional methods |
ODYSSEY Trial Spotlight | Phase 2b trial for CLS-AX nears completion, with data expected in late September 2024. Positive results could significantly impact stock performance |
Financial Health Check | Q2 2024 shows improved operational efficiency, with $29M cash runway until Q3 2025. Analysts' price targets range up to $5.00, signaling potential upside |
Market Positioning | CLSD faces stiff competition but offers unique delivery method. Expansion into geographic atrophy and international markets could broaden revenue streams |
Clearside Biomedical Inc Earnings Call Summary for Q3/2024
- CLS-AX Phase 2b trial for wet AMD shows 84% reduction in injection frequency; Phase 3 trials planned for H2 2025
- Cash reserves of $23.6M expected to fund operations into Q3 2025; exploring GA treatment with $20B+ market potential
- Collaborations with Arctic Vision and REGENXBIO progressing, utilizing Clearside's SCS Microinjector technology
- New leadership: Tony Gibney as Board Chair, Victor Chong as CMO and EVP of R&D confident in FDA approval for CLS-AX redosing
- Innovative approach to GA treatment focuses on choroidal damage; timeline for IND submission not yet defined
Last Updated: 2024-11-13, 11:44 a/m
Read Full TranscriptCompare CLSD to Peers and Sector
Metrics to compare | CLSD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCLSDPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.4x | −0.5x | −0.5x | |
PEG Ratio | −0.10 | 0.06 | 0.00 | |
Price/Book | −2.2x | 0.9x | 2.6x | |
Price / LTM Sales | 10.0x | 1.2x | 3.0x | |
Upside (Analyst Target) | - | 178.3% | 55.6% | |
Fair Value Upside | Unlock | 22.5% | 10.1% | Unlock |
Analyst Ratings
7 Buy
0 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 6.000
(+491.13% Upside)
Earnings
Latest Release
Nov 12, 2024
EPS / Forecast
-0.10 / -0.12
Revenue / Forecast
1.04M / 130.00K
People Also Watch
FAQ
What Is the Clearside Biomedical (CLSD) Stock Price Today?
The Clearside Biomedical stock price today is 1.015
What Stock Exchange Does Clearside Biomedical Trade On?
Clearside Biomedical is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for Clearside Biomedical?
The stock symbol for Clearside Biomedical is "CLSD."
What Is the Clearside Biomedical Market Cap?
As of today, Clearside Biomedical market cap is 76.98M.
What is Clearside Biomedical Earnings Per Share?
The Clearside Biomedical EPS is -0.453.
What Is the Next Clearside Biomedical Earnings Date?
Clearside Biomedical will release its next earnings report on Mar 27, 2025.
From a Technical Analysis Perspective, Is CLSD a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.